Since the SCA1 cohort was characterized by distinct changes in Glc and Asp as opposed to SCA14, despite a significant shorter disease duration, these metabolites might point to metabolic pathways differing between SCA14 and SCA1. The gene discussed is PRKCG; the disease is spinocerebellar ataxia type 1.